NCT07008638
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Masonic Cancer Center Minneapolis, Minnesota, United States
Clinical trial condition
TP53
Explore clinical trials studying TP53. Study availability and eligibility vary by location and protocol.
6 public trials
5 recruiting studies
TP53 trial results
NCT05735717
- Conditions
- AML, Acute Leukemia, Acute Lymphoblastic Leukemia, +74 more
- Locations
-
- University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
Recruiting
ALPINE: Maintenance Letrozole/Abemaciclib
NCT06366347
- Conditions
- Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +12 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Dana-Farber Cancer Institute at Foxborough Foxborough, Massachusetts, United States
- Conditions
- Large B-cell Lymphoma, TP53
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
NCT06158399
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Bing Xu Xiamen, Fujian, China
Not Yet Recruiting
Safety and Efficacy of Aumolertinib Combined With Anlotinib as 1st Line Treatment in Advanced Lung Cancer EGFR Mutation With TP53 Co-Mutation
NCT05778149
- Conditions
- Anlotinib, Aumolertinib, EGFR Activating Mutation, +2 more
- Locations
-
Not specified